Richard Mulligan

CIK: 0001376247

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)5 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

SANA

Sana Biotechnology, Inc.

Director

IFF

INTERNATIONAL FLAVORS & FRAGRANCES INC

Director

BHC

Bausch Health Companies Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

SANA
Sana Biotechnology, Inc.
Jun 4, 2026
Award(A)
Stock Option (Right to Buy)
Direct
90K shares-
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
May 1, 2026
Exercise(M)
Direct
1.7K shares-
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
Apr 29, 2026
Award(A)
Restricted Stock Units
Direct
2.9K shares-
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
Nov 3, 2025
Award(A)
Restricted Stock Units
Direct
1.7K shares-
SANA
Sana Biotechnology, Inc.
Jun 5, 2025
Award(A)
Stock Option (Right to Buy)
Direct
80K shares-
BHC
Bausch Health Companies Inc.
May 16, 2025
Award(A)
Direct
54.3K shares-
SANA
Sana Biotechnology, Inc.
Sep 25, 2024
Sale(S)
Direct
150K shares at avg. $3.89$583K
SANA
Sana Biotechnology, Inc.
Sep 24, 2024
Sale(S)
Direct
150K shares at avg. $4.08$613K

		Type	Shares	Price		Ownership
Jun 4, 2026	SANA Sana Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	90,000	-	-	Direct
May 1, 2026	IFF INTERNATIONAL FLAVORS & FRAGRANCES INC	Exercise(M)	1,712	-	$0	Direct
Apr 29, 2026	IFF INTERNATIONAL FLAVORS & FRAGRANCES INC	Award(A) Restricted Stock Units	2,903	-	-	Direct
Nov 3, 2025	IFF INTERNATIONAL FLAVORS & FRAGRANCES INC	Award(A) Restricted Stock Units	1,712	-	-	Direct
Jun 5, 2025	SANA Sana Biotechnology, Inc.	Award(A) Stock Option (Right to Buy)	80,000	-	-	Direct
May 16, 2025	BHC Bausch Health Companies Inc.	Award(A)	54,347	-	-	Direct
Sep 25, 2024	SANA Sana Biotechnology, Inc.	Sale(S)	150,000	$3.89	$583,170	Direct
Sep 24, 2024	SANA Sana Biotechnology, Inc.	Sale(S)	150,000	$4.08	$612,570	Direct

1-8 of 8 transactions

About Mulligan Richard

Mulligan Richard (SEC CIK 0001376247) files insider reports with the SEC as Director of Sana Biotechnology, Inc. (SANA), Director of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) and Director of Bausch Health Companies Inc. (BHC).

Signal8 holds 8 ownership filings by Mulligan Richard (1 Form 3, 7 Form 4), filed between Sep 26, 2024 and Jun 5, 2026. Those filings report 8 transactions, from Sep 24, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mulligan Richard's filings is in SEATTLE, WA.

Recent filings by Mulligan Richard

Jun 4, 2026: Grant or award of SANA derivative securities (Form 4, code A).
May 1, 2026: Option exercise of IFF shares (Form 4, code M).
Apr 29, 2026: Grant or award of IFF derivative securities (Form 4, code A).
Nov 3, 2025: Grant or award of IFF derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of SANA derivative securities (Form 4, code A).

Other insiders filing for Sana Biotechnology, Inc. (SANA)

Bishop Hans Edgar, Director
PATEL DHAVALKUMAR DHIRAJLAL, EVP, Chief Scientific Officer
Yang Patrick Y, Director
Rosiello Robert L., Director
Seitz Michelle, Director
REICIN ALISE, Director

How to read Form 4 transaction codes